MONTANOVA CAPITAL, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001569064
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2026 · 96 positions · Total reported value $5.47B · Top-10 concentration 49.1% · Updated 2026-10-24
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
Turnover: 47.3% · 21 new · 17 cut · 14 exited
Active Share (vs S&P 500): 88.7% · vs QQQ: 90.7% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q1 2026 → Q2 2026): +26.5% · vs SPY +11.7% · Prev Value $3.92B — last quarter positions weighted by this quarter price moves · ranking
In its Q2 2026 13F filing, MONTANOVA CAPITAL, LLC disclosed 96 equity positions with a combined reported value of $5.47B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 49.1% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.
The largest disclosed positions as of Q2 2026 were SPY ($709.43M), MANE ($512.53M), ARQT ($326.10M). By sector, the heaviest allocations are Health Care 50.9%, Technology 14.2%. Versus the prior quarter, allocation shifted toward Other (+3.2pp), Technology (+2.8pp) and away from Industrials (-0.6pp), Consumer Discretionary (-1.5pp).
Versus the prior quarter, MONTANOVA CAPITAL, LLC opened 21 new positions, trimmed 17 and fully exited 14, a turnover rate of 47.3% of positions. The portfolio's overlap with the prior quarter was 68% of names.
The largest new positions opened in Q2 2026 were AVLN ($82.40M), HUT ($77.35M), APH ($47.48M).
Of the 14 positions fully exited versus the prior quarter, the largest were APLS ($141.55M), KALV ($95.99M), ERAS ($55.58M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2026)
Fully Exited (vs previous quarter)
- APLS APELLIS PHARMACEUTICALS INC · prev qtr: $141.55M
- KALV KALVISTA PHARMACEUTICALS INC · prev qtr: $95.99M
- ERAS ERASCA INC · prev qtr: $55.58M
- LTH LIFE TIME GROUP HOLDINGS INC · prev qtr: $13.75M
- WING WINGSTOP INC COM · prev qtr: $9.22M
- COHR COHERENT CORP · prev qtr: $7.15M
- MDT MEDTRONIC PLC · prev qtr: $6.26M
- KZR KEZAR LIFE SCIENCES INC · prev qtr: $5.32M
Insider Transactions (Form 4)
Latest MONTANOVA CAPITAL, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
| Transaction date | Activity | Security | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-08-20 | Opt exercise | Veradermics, Inc | 151,000 | — | SEC filing |
| 2026-08-20 | Opt exercise | Veradermics, Inc | 149,000 | — | SEC filing |
| 2026-08-19 | Sell | Veradermics, Inc | 59,399 | $107.25 | SEC filing |
| 2026-08-19 | Sell | Veradermics, Inc | 690,601 | $107.25 | SEC filing |
Fund Profile
Montanova Capital, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 96 positions worth $5.47B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-79962 (status: Approved), registered 2014-06-26
- Regulatory AUM (Form ADV): $7.87B as of 2026-07-01
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 3 private funds, of which 3 hedge funds
- Website: montanova.com
Portfolio Structure
- 96 positions · $5.47B reported value (Q2 2026)
- Top 10 holdings = 49.1% of reported value
- Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 13.0%
- Average position size: $56.96M
Sector Tilt
- Health Care 50.9%
- Information Technology 14.5%
- Consumer Discretionary 8.3%
- (classified holdings cover 83% of value)
Quarterly Activity
- Q2 2026: 21 new, 26 added, 17 reduced, 14 exited
- 32 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
950.00K | $709.43M | 12.97% | Add | |
| 2 |
|
4.17M | $512.53M | 9.37% | Hold | |
| 3 |
|
12.44M | $326.10M | 5.96% | Add | |
| 4 |
|
7.07M | $204.18M | 3.73% | Reduce | |
| 5 |
|
1.14M | $173.51M | 3.17% | Reduce | |
| 6 |
|
4.52M | $156.87M | 2.87% | Add | |
| 7 |
|
11.55M | $154.52M | 2.83% | Hold | |
| 8 |
|
10.29M | $153.07M | 2.80% | Hold | |
| 9 |
|
257.24K | $149.43M | 2.73% | Hold | |
| 10 |
|
4.78M | $147.26M | 2.69% | Reduce | |
| 11 |
|
304.63K | $145.48M | 2.66% | Add | |
| 12 |
|
720.61K | $144.19M | 2.64% | Add | |
| 13 |
|
8.30M | $118.64M | 2.17% | Hold | |
| 14 |
|
1.41M | $117.98M | 2.16% | Add | |
| 15 |
|
310.26K | $115.95M | 2.12% | Hold | |
| 16 |
|
11.19M | $113.36M | 2.07% | Hold | |
| 17 |
|
2.33M | $111.18M | 2.03% | Add | |
| 18 |
|
175.81K | $99.03M | 1.81% | Add | |
| 19 |
|
4.09M | $98.55M | 1.80% | Add | |
| 20 |
|
8.58M | $94.07M | 1.72% | Hold | |
| 21 |
|
3.55M | $85.90M | 1.57% | Reduce | |
| 22 |
|
2.50M | $82.40M | 1.51% | New | |
| 23 |
|
226.05K | $79.72M | 1.46% | Add | |
| 24 |
|
670.00K | $77.35M | 1.42% | New | |
| 25 |
|
333.10K | $66.83M | 1.22% | Add | |
| 26 |
|
214.98K | $63.42M | 1.16% | Add | |
| 27 |
|
246.76K | $58.56M | 1.07% | Add | |
| 28 |
|
9.44M | $55.71M | 1.02% | Add | |
| 29 |
|
22.93M | $51.37M | 0.94% | Add | |
| 30 |
|
7.21M | $51.16M | 0.94% | Add | |
| 31 |
|
2.02M | $50.50M | 0.92% | Add | |
| 32 |
|
9.74M | $49.47M | 0.91% | Add | |
| 33 |
|
204.86K | $48.83M | 0.89% | Reduce | |
| 34 |
|
4.39M | $48.60M | 0.89% | Add | |
| 35 |
|
269.30K | $47.48M | 0.87% | New | |
| 36 |
|
101.80K | $46.74M | 0.85% | Add | |
| 37 |
|
2.84M | $46.57M | 0.85% | Hold | |
| 38 |
|
383.30K | $45.35M | 0.83% | Reduce | |
| 39 |
|
789.72K | $45.00M | 0.82% | Reduce | |
| 40 |
|
603.00K | $44.53M | 0.81% | New | |
| 41 |
|
1.19M | $44.39M | 0.81% | Add | |
| 42 |
|
171.90K | $37.99M | 0.69% | New | |
| 43 |
|
151.32K | $34.32M | 0.63% | New | |
| 44 |
|
83.60K | $31.58M | 0.58% | New | |
| 45 |
|
14.10M | $30.88M | 0.56% | Reduce | |
| 46 |
|
6.38M | $29.72M | 0.54% | Add | |
| 47 |
|
64.13K | $26.65M | 0.49% | Reduce | |
| 48 |
|
12.34M | $25.18M | 0.46% | Hold | |
| 49 |
|
4.30M | $19.69M | 0.36% | Add | |
| 50 |
|
101.20K | $17.29M | 0.32% | New | |
Loading forecast…
Holdings Prediction Model
Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.
The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.
Latest-Quarter Accuracy (2026-Q2)
P 70% R 70% F1 70% (modelled on 2026-Q1; 7/10 hit)
Historical Backtest (10 quarters)
Avg precision 73% · recall 73% · F1 73% · avg rank error 2.4 · Top-10 turnover 29%
| Quarter | Prec. | Recall | F1 | Predicted Top 10 | Actual Top 10 |
|---|---|---|---|---|---|
| 2024-Q1 | 70% | 70% | 70% | BHVN · ACLX · RARE · RPRX · KURA · EYPT · ITCI · INSM · META · ETNB | SPY · BHVN · KURA · ACLX · QQQ · META · RARE · ARQT · EYPT · ETNB |
| 2024-Q2 | 70% | 70% | 70% | SPY · BHVN · KURA · ACLX · RARE · ARQT · QQQ · META · ETNB · EYPT | SPY · BHVN · INSM · KURA · ITCI · ARQT · RARE · META · ACLX · UNH |
| 2024-Q3 | 90% | 90% | 90% | SPY · BHVN · INSM · KURA · ITCI · ARQT · UNH · AAPL · RARE · META | SPY · BHVN · KURA · INSM · ITCI · ARQT · META · UNH · BNTC · AAPL |
| 2024-Q4 | 70% | 70% | 70% | SPY · BHVN · KURA · INSM · ITCI · ARQT · UNH · META · BNTC · AAPL | BHVN · SPY · ARQT · ITCI · LEGN · BNTC · INSM · META · ETNB · AMZN |
| 2025-Q1 | 90% | 90% | 90% | BHVN · SPY · ARQT · BNTC · ITCI · LEGN · INSM · META · ETNB · APO | SPY · ARQT · BHVN · BNTC · LEGN · INSM · ETNB · META · ITCI · RARE |
| 2025-Q2 | 70% | 70% | 70% | SPY · ARQT · BHVN · BNTC · LEGN · INSM · ETNB · META · ITCI · RARE | SPY · ARQT · IWM · ETNB · LEGN · META · BNTC · KO · RARE · GE |
| 2025-Q3 | 80% | 80% | 80% | SPY · ARQT · IWM · ETNB · LEGN · META · BNTC · KO · RARE · NVDA | SPY · ARQT · BNTC · META · LEGN · ETNB · IMTX · KO · GE · NVDA |
| 2025-Q4 | 60% | 60% | 60% | SPY · ARQT · BNTC · META · LEGN · ETNB · KO · IMTX · GE · NVDA | SPY · ARQT · ARKG · BNTC · LEGN · EYPT · RCUS · IMTX · BHVN · META |
| 2026-Q1 | 60% | 60% | 60% | SPY · ARQT · ARKG · BNTC · LEGN · EYPT · RCUS · BHVN · IMTX · META | ARQT · MANE · SPY · PVLA · APLS · LEGN · BNTC · CAPR · IMTX · RCUS |
| 2026-Q2 ★ | 70% | 70% | 70% | ARQT · MANE · SPY · LEGN · PVLA · APLS · CAPR · BNTC · RCUS · EYPT | SPY · MANE · ARQT · LEGN · PVLA · AVBP · BNTC · BHVN · AMD · RCUS |
★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.
FAQ
What did MONTANOVA CAPITAL, LLC buy in 2026-Q2?
In its 2026-Q2 13F filing, MONTANOVA CAPITAL, LLC reported 96 equity positions worth $5.47B in aggregate; its largest disclosed positions were SPY ($709.43M), MANE ($512.53M), ARQT ($326.10M).
How large is MONTANOVA CAPITAL, LLC's portfolio?
MONTANOVA CAPITAL, LLC reported $5.47B of long equity holdings across 96 positions as of 2026-Q2. Top-10 holdings account for 49.1% of reported value.
What is MONTANOVA CAPITAL, LLC's investment style?
HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.